Drug Shortage Report for TARO-BUDESONIDE

Last updated on 2025-01-28 History
Report ID 173505
Drug Identification Number 02494264
Brand name TARO-BUDESONIDE
Common or Proper name BUDESONIDE
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) BUDESONIDE
Strength(s) 0.125MG
Dosage form(s) SUSPENSION
Route of administration INHALATION
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 2
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-04-14
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2025-01-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v50 2025-01-28 French Compare
v49 2025-01-28 English Compare
v48 2025-01-07 French Compare
v47 2025-01-07 English Compare
v46 2024-12-13 French Compare
v45 2024-12-13 English Compare
v44 2024-11-11 French Compare
v43 2024-11-11 English Compare
v42 2024-09-09 French Compare
v41 2024-09-09 English Compare
v40 2024-06-14 French Compare
v39 2024-06-14 English Compare
v38 2024-05-09 French Compare
v37 2024-05-09 English Compare
v36 2024-05-07 French Compare
v35 2024-05-07 English Compare
v34 2024-01-05 French Compare
v33 2024-01-05 English Compare
v32 2023-08-16 French Compare
v31 2023-08-16 English Compare

Showing 1 to 20 of 50